Alzheimer’s disease

It may also hold opportunities for treating more common forms of dementia, such as Alzheimer’s disease. The new treatment, dubbed…

Studies show that stroke reigns as the third-most common cause of death in developed countries and remains one of the leading…

Raheel Shah, Business Development Director, BDR Pharmaceuticals highlights that the rise in Alzheimer's disease prevalence in…

Aptamer Group has successfully developed a panel of Optimer binders to a novel Alzheimer’s disease biomarker

The study, led by Dr Mark Logue, a statistician in the National Center for PTSD at the Veterans Affairs (VA) Boston Healthcare…

Current diagnosis of Alzheimer’s Disease (AD) is often done through clinical assessment and routine imaging tests which may not…

Promising early results pave the way for developing the world’s first non-invasive, wearable electrical stimulation system to…

Currently, amyloid PET and Abeta ratio in cerebrospinal fluid are used for detecting amyloid aggregates in the brain but a…

The results point to a potential role in Alzheimer’s disease treatment for drugs that reduce the iron burden in the brain.…

The findings highlight the importance of future studies on the risk-benefit ratio of antiepileptic drugs in old adults and…